Favitab 200 mg (Tablet)
Unit Price: ৳ 200.00 (2 x 10: ৳ 4,000.00)
Strip Price: ৳ 2,000.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Favipiravir |
| Company | Ibn sina pharmaceuticals ltd |
Indications
- Treatment of novel or re-emerging pandemic influenza virus infections
- Limited to cases in which other influenza antiviral drugs are ineffective or not sufficiently effective
Description
- Favitab is an approved influenza antiviral in Japan
- Selectively inhibits the RNA polymerase of the influenza virus
- May be effective in treating COVID-19
Pharmacology
- Favipiravir is metabolized into favipiravir ribosyl triphosphate
- Favipiravir RTP selectively inhibits RNA polymerase of the influenza virus
- Effective against all types and sub-types of human influenza A, B, and C viruses in vitro
Dosage & Administration
- Usual adult dosage is 1600 mg of Favipiravir administered orally twice daily on Day 1
- Followed by 600 mg orally twice daily from Day 2 to Day 5
- Total treatment duration should be 5 days
Interaction
- Animal studies show decreased RBC production and liver function parameter changes
- Toxicity information regarding Favitab in humans is not readily available
Contraindications
- Contraindicated for pregnant women and women who may possibly be pregnant
Side Effects
- Most common side effects are diarrhea and increase of blood uric acid levels
Pregnancy & Lactation
- Favipiravir may cause delayed development or death of embryos during early pregnancy
- Should not be given during pregnancy
Precautions & Warnings
- Should not be given to pregnant women
- Confirmation of non-pregnancy required in women of childbearing potential before use
- Thorough contraception measures from start of treatment to 7 days after end of treatment
- Caution should be taken for hepatic and renal impaired patients
Use in Special Populations
- Favitab is approved as an experimental drug
- Further studies needed about its efficacy, toxic reactions, and use in children
Overdose Effects
- Animal studies show decreased RBC production and liver function parameter changes
- Toxicity information regarding Favitab in humans is not readily available
Therapeutic Class
- Anti-viral drugs
Storage Conditions
- Keep below 30°C temperature
- Protected from light and moisture
- Keep out of the reach of children